[Bronchodilator effect of hexoprenalin administered in a dosed aerosol form (spirographic evaluation)].
D000328:Adult; D000368:Aged; D001249:Asthma / Q000188:drug therapy*; D001794:Blood Pressure / Q000187:drug effects; D001991:Bronchitis / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D002396:Catechols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D002908:Chronic Disease; D004983:Ethanolamines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D010627:Phenethylamines / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D011674:Pulse / Q000187:drug effects; D013147:Spirometry
D001993:Bronchodilator Agents; D002396:Catechols; D004983:Ethanolamines; D010627:Phenethylamines
Efecto broncodilatador de la hexoprenalina administrada en aerosol dosificador (objetivación espirográfica.